Enhanced curcumin permeability by SLN formulation: The PAMPA approach

LWT

Volumn 66, Issue , 2016, Pages 475-483

  Righeschi, Chiara ^a   Bergonzi, Maria Camilla ^a   Isacchi, Benedetta ^a   Bazzicalupi, Carla ^a   Gratteri, Paola ^a   Bilia, Anna Rita ^a  

^a UNIVERSITY OF FLORENCE   (Italy)

Author keywords

Curcumin; In vitro release; Parallel artificial permeability assay; Solid lipid nanoparticles; Stability studies

Indexed keywords

BIOCHEMISTRY; NANOPARTICLES; PARTICLE SIZE; PARTICLE SIZE ANALYSIS; TARGETED DRUG DELIVERY;

ARTIFICIAL PERMEABILITIES; CURCUMIN; IN-VITRO; SOLID LIPID NANOPARTICLE (SLN); STABILITY STUDY;

CONTROLLED DRUG DELIVERY;

EID: 84950133565     PISSN: 00236438     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.lwt.2015.11.008     Document Type: Article

References (55)

1. Aditya N.P., Macedo A.S., Doktorovova S., Souto E.B., Kim S., Chang P.S., et al. Development and evaluation of lipid nanocarriers for quercetin delivery: a comparative study of solid lipid nanoparticles (SLN), nanostructured lipid carriers (NLC), and lipid nanoemulsions (LNE). LWT-Food Science and Technology 2014, 59:115-121.
2. Aggarwal B.B., Kuiken V., Michelle E., Laxmi I.H., Kuzhuvelil H.B., Bokyung S. Molecular targets of nutraceuticals derived from dietary spices: potential role in suppression of inflammation and tumorigenesis. Experimental Biology and Medicine 2009, 234:825-849.
3. Aggarwal B.B., Kumar A., Bharti A.C. Anticancer potential of curcumin: preclinical and clinical studies. Anticancer Research 2003, 23:363-398.
4. Anand P., Kunnumakkara A.B., Newman R.A., Aggarwal B.B. Bioavailability of curcumin: problems and promises. Molecular Pharmacology 2007, 4:807-818.
5. Bergonzi M.C., Hamdouch R., Mazzacuva F., Isacchi B., Bilia A.R. Optimization, characterization and in vitro evaluation of curcumin microemulsions. LWT-Food Sciences and Technology 2014, 59:148-155.
6. Bisht S., Feldmann G., Soni S., Ravi R., Karikar C., Maitra A., et al. Polymeric nanoparticle-encapsulated curcumin (''nanocurcumin''): a novel strategy for human cancer therapy. Journal of Nanobiotechnology 2007, 17. 5-3.
7. Castelli F., Puglia C., Sarpietro M.G., Rizza L., Bonina F. Characterization of indomethacin-loaded lipid nanoparticles by differential scanning calorimetry. International Journal of Pharmaceutics 2005, 304:231-238.
8. Chakraborty S., Shukla D., Mishra B., Singh S. Lipid-an emerging platform for oral delivery of drugs with poor bioavailability. European Journal of Pharmaceutics and Biopharmaceutics 2009, 73:1-15.
9. Chaurasia S., Patel R.R., Chaubey P., Kumar N., Khan G., Mishra B. Lipopolysaccharide based oral nanocarrier for the improvement of bioavailability and anticancer efficacy of curcumin. Carbohydrate Polymers 2015, 130:9-17.
10. Das S., Ng W.K., Kanaujia P., Kim S., Tan R.B.H. Formulation design, preparation and physicochemical characterizations of solid lipid nanoparticles containing a hydrophobic drug: effects of process variables. Colloids and Surfaces B Biointerfaces 2011, 88:483-489.
11. Devasena T., Rajasekaran K.N., Gunasekaran G., Viswanathan P., Venugopal P. Anticarcinogenic effect of bis-1,7-(2-hydroxyphenyl)-hepta-1,6-diene-3,5-dione a curcumin analog on DMH-induced colon cancer model. Pharmacological Research 2003, 47:133-140.
12. Dhillon N., Aggarwal B.B., Newman R.A., Wolff R.A., Kunnumakkara A.B., Abbruzzese J.L., et al. Phase II trial of curcumin in patients with advanced pancreatic cancer. Clinical Cancer Research 2008, 14:4491-4499.
13. Freitas C., Müller R.H. Correlation between long-term stability of solid lipid nanoparticles (SLN) and crystallinity of the lipid phase. European Journal of Pharmaceutics and Biopharmaceutics 1999, 47:125-132.
14. Hazzah H.A., Farid R.M., Nasra M.M.A., EL-Massik M.A., Abdallah O.Y. Lyophilized sponges loaded with curcumin solid lipid nanoparticles for buccal delivery: development and characterization. International Journal of Pharmaceutics 2015, 492:248-257.
15. Jia L. Nanoparticle formulation increases oral bioavailability of poorly soluble drugs: approaches experimental evidences and theory. Current Nanoscience 2005, 1:237-243.
16. Kakkar V., Mishra A.K., Chuttani K., Kaur I.P. Proof of concept studies to confirm the delivery of curcumin loaded solid lipid nanoparticles (C-SLNs) to brain. International Journal of Pharmaceutics 2013, 448:354-359.
17. Kakkar V., Singh S., Singla D., Kaur I.P. Exploring solid lipid nanoparticles to enhance the oral bioavailability of curcumin. Molecular Nutrition & Food Research 2011, 55:495-503.
18. Kansy M., Avdeef A., Fischer H. Advances in screening for membrane permeability: high-resolution PAMPA for medicinal chemists. Drug Discovery Todays: Technologies 2004, 4:349-355.
19. Lao C.D., Ruffin M.T., Normolle D., Heath D.D., Murray S.I., Bailey J.M., et al. Dose escalation of a curcuminoid formulation. BMC Complementary and Alternative Medicines 2006, 17:6-10.
20. Lim S.J., Kim C.K. Formulation parameters determining the physicochemical characteristics of solid lipid nanoparticles loaded with all-trans retinoic acid. International Journal of Pharmaceutics 2002, 243:135-146.
21. Maiti K., Mukherjee K., Gantait A., Saha B.P., Mukherjee P.K. Curcumin phospholipid complex: preparation, therapeutic evaluation and pharmacokinetic study in rats. International Journal of Pharmaceutics 2007, 330:155-163.
22. Mehnert W., Mader K. Solid lipid nanoparticles: production, characterization and applications. Advanced Drug Delivery Reviews 2001, 47:165-196.
23. Mehnert W., Mäder K. Solid lipid nanoparticles. Production, characterization and applications. Advanced Drug Delivery Reviews 2012, 64:83-101.
24. Menon V.P., Sudheer A.R. Antioxidant and anti-inflammatory properties of curcumin. Advances in Experimental Medicines and Biology 2007, 595:105-125.
25. zur Mühlen A., Schwarz C., Mehnert W. Solid lipid nanoparticles (SLN) for controlled drug delivery-drug release and release mechanism. European Journal of Pharmaceutics and Biopharmaceutics 1998, 45:149-155.
26. Mulik R.S., Mönkkönenc J., Juvonend R.O., Mahadika K.R., Paradkarb A.R. Transferrin mediated solid lipid nanoparticles containing curcumin: enhanced in vitro anticancer activity by induction of apoptosis. International Journal of Pharmaceutics 2010, 5:190-203.
27. Müller R.H., Mader K., Gohla S. Solid lipid nanoparticles (SLN) for controlled drug delivery - a review of the state of art. European Journal of Pharmaceutics and Biopharmaceutics 2000, 50:161-177.
28. Müller R.H., Mehnert W., Lucks J.-S., Schwarz C., Zur mühlen A., Meyhers H., et al. Solid lipid nanoparticles (SLN)-an alternative colloidal carrier system for controlled drug delivery. European Journal of Pharmaceutics and Biopharmaceutics 1995, 41:62-69.
29. Müller R.H., Rühl D., Runge S., Schulze-Forster K., Mehnert W. Cytotoxicity of solid lipid nanoparticles as a function of the lipid matrix and the surfactant. Pharmaceutical Research 1997, 14:458-462.
30. Nassimi M., Schleh C., Lauenstein H.D., Hussein R., Hoymann H.G., Koch W., et al. Toxicological evaluation of inhaled solid lipid nanoparticles used as a potential drug delivery system for the lung. Colloids and Surfaces B: Biointerfaces 2010, 75:107-116.
31. Nayak A.P., Tiyaboonchai W., Patankar S., Madhusudhan B., Souto E.B. Curcuminoids-loaded lipid nanoparticles: novel approach towards malaria treatment. Colloids and Surfaces B: Biointerfaces 2010, 81:263-273.
32. Negi P.S., Jayaprakasha G.K., Jagan Mohan Rao L., Sakariah K.K. Antibacterial activity of turmeric oil: a byproduct from curcumin manufacture. Journal of Agricultural and Food Chemistry 1999, 47:4297-4300.
33. Noack A., Oidtmann J., Kutza J., Mäder K. In vitro digestion of curcuminoid-loaded lipid nanoparticles. Journal of Nanoparticles Research 2012, 14:1113.
34. Paliwal R., Rai S., Vaidya B., Khatri K., Goyal A.K., Mishra N., et al. Effect of lipid core material on characteristics of solid lipid nanoparticles designed for oral lymphatic delivery. Nanomedicine 2009, 5:184-191.
35. Pan M.H., Huang T.M., Lin J.K. Biotransformation of curcumin through reduction and glucuronidation in mice. Drug Metabolism and Disposition 1999, 27:486-494.
36. Park J. Anti-carcinogenic properties of curcumin on colorectal cancer. World Journal of Gastrointestinal Oncology 2010, 4:169-176.
37. Porter C.J., Wasan K.M., Constantinides P. Lipid-based systems for the enhanced delivery of poorly water soluble drugs. Advanced Drug Delivery Reviews 2008, 60:615-616.
38. Pouton C. Formulation of poorly water-soluble drugs for oral administration: physicochemical and physiological issues and the lipid formulation classification system. European Journal of Pharmaceutical Sciences 2006, 29:278-287.
39. Rao T.S., Basu N., Siddiqui H.H. Anti-inflammatory activity of curcumin analogues. Indian Journal of Medical Research 1982, 75:574-578.
40. Reddy L.H. Etoposide-loaded nanoparticles made from glyceride lipids: formulation, characterization, in vitro drug release, and stability evaluation. AAPS PharmSciTech 2005, 6:155-166.
41. Ruby A.J., Kuttan G., Babu K.D., Rajasekharan K.N., Kuttan R. Anti-tumour and antioxidant activity of natural curcuminoids. Cancer Letters 1995, 94:79-83.
42. Sanna V., Gavini E., Cossu M., Rassu G., Giunchedi P. Solid lipid nanoparticles (SLN) as carriers for the topical delivery of econazole nitrate: in-vitro characterization, ex-vivo and in-vivo studies. Journal Pharmaceutics and Pharmacology 2007, 59:1057-1064.
43. Sanoj Rejinold N., Sreerekha P.R., Chennazhi K.P., Nair S.V., Jayakumar R. Biocompatible, biodegradable and thermo-sensitive chitosan-g-poly (N-isopropylacrylamide) nanocarrier for curcumin drug delivery. International Journal of Biological Macromolecules 2011, 49:161-172.
44. Schwarz C., Mehnert W. Solid lipid nanoparticles (SLN) for controlled drug delivery II. Drug incorporation and physicochemical characterization. Journal of Microencapsulation 1999, 16:205-213.
45. Selvam R., Subramanian L., Gayathri R., Angayarkanni N. The anti-oxidant activity of turmeric (Curcuma longa). Journal of Ethnopharmacology 1995, 47:59-67.
46. Shankar T.N., Shantha N.V., Ramesh H.P., Murthy I.A., Murthy V.S. Toxicity studies on turmeric (Curcuma longa): acute toxicity studies in rats, guineapigs & monkeys. Indian Journal of Experimental Biology 1980, 18:73-75.
47. Sharma O.P. Antioxidant activity of curcumin and related compounds. Biochemical Pharmacology 1976, 25:1811-1812.
48. Sharma M., Manoharlal R., Puri N., Prasad R. Antifungal curcumin induces reactive oxygen species and triggers an early apoptosis but prevents hyphae development by targeting the global repressor TUP1 in Candida albicans. Bioscience Reports 2010, 30:391-404.
49. Shishodia S., Singh T., Chaturvedi M.M. Modulation of transcription factors by curcumin. The molecular targets and therapeutics of curcumin in health and disease. Advances in experimental medicine and biology 2007, Vol. 995:127-141. Springer Publication, New York.
50. Silva A.C., González-Mira E., García M.L., Egea M.A., Fonseca J., Silva R., et al. Preparation, characterization and biocompatibility studies on risperidone-loaded solid lipid nanoparticles (SLN): high pressure homogenization versus ultrasound. Colloids and Surfaces B: Biointerfaces 2011, 86:158-165.
51. Souto E.B., Mehnert W., Müller R.H. Polymorphic behaviour of Compritol 888 ATO as bulk lipid and as SLN and NLC. Journal of Microencapsulation 2006, 23:417-433.
52. Sun J., Bi C., Chan H.M., Sun S., Zhang Q., Zheng Y. Curcumin-loaded solid lipid nanoparticles have prolonged in vitro antitumour activity, cellular uptake and improved in vivo bioavailability. Colloids and Surfaces B: Biointerface 2013, 11:367-375.
53. Tiyaboonchai W., Tungpradit W., Plianbangchang P. Formulation and characterization of curcuminoids loaded solid lipid nanoparticles. International Journal of Pharmaceutics 2007, 337:299-306.
54. Vitorino C., Carvalho F.A., Almeida A.J., Sousa J.J., Pais A.A. The size of solid lipid nanoparticles: an interpretation from experimental design. Colloids and Surfaces B: Biointerfaces 2011, 84:117-130.
55. Westesen K., Bunjes H., Koch M.H.J. Physicochemical characterization of lipid nanoparticles and evaluation of their drug loading capacity and sustained release potential. Journal of Controlled Release 1997, 48:223-236.